ICFDA Warning on Drug Discontinuation

Taper off very, very, very slowly!!!!!!!!!!!!!!

Dropping “cold turkey” off any medication, most especially mind altering medications, can often be MORE DANGEROUS than staying on the drugs. With antidepressants the FDA has now warned that any abrupt change in dose, whether increasing or decreasing the dose, can produce suicide, hostility, or psychosis – generally a manic psychosis when you then get your diagnosis for Bipolar Disorder. Of course drug-induced Bipolar is temporary so you need to learn more about that if it has already happened to you. We have a DVD on explaining this and how to recover from it: “Bipolar? Are You Really Bipolar or Misdiagnosed Due to the Use of or Abrupt Discontinuation of an Antidepressant”: https://store.drugawareness.org/product/bipolar-disorder-streaming/

The most dangerous and yet the most common mistake someone coming off any antidepressant, atypical antipsychotic, or benzodiazaphine makes is coming off these drugs too rapidly. Tapering off VERY, VERY, VERY SLOWLY–OVER MONTHS OR YEARS (The general rule of thumb for those on antidepressants (ANY antidepressant, not just the current antidepressant – add up all time on any of them) for less than a year is to take half the amount of time on them to wean off and for long-term users for each 5 years on psychiatric drugs of any kind  the general rule of thumb is at least a year or more.), NOT JUST WEEKS OR MONTHS!—has proven the safest and most effective method of withdrawal from these types of medications. Thus the body is given the time it needs to readjust its own chemical levels. Patients must be warned to come very slowly off these drugs by shaving minuscule amounts off their pills each day, as opposed to cutting them.

WARNING: The practice of taking a pill every other day throws you into withdrawal every other day and can be very dangerous when you consider the FDA warnings on abrupt changes in dose.

This cannot be stressed strongly enough! This information on EXTREMELY gradual withdrawal is the most critical piece of information that someone facing withdrawal from these drugs needs to have.


No matter how few or how many side effects you have had on these antidepressants, withdrawal is a whole new world. The worst part of rapid withdrawal can be delayed for several months AFTER you quit. So even if you think you are doing okay you quickly find that it becomes much worse. If you do not come off correctly and rebuild your body as you do, you risk:

  • Creating bouts of overwhelming depression
  • Producing a MUCH longer withdrawal and recovery period than if you had come off slowly
  • Overwhelming fatigue causing you to be unable to continue daily tasks or costing your job
  • Having a psychotic break brought on by the terrible insomnia from the rapid withdrawal, and then being locked in a psychiatric ward and being told you are either schizophrenic or most likely that you are Bipolar.
  • Ending up going back on the drugs (each period on the drugs tends to be more dangerous and problematic than the previous time you were on the drugs) and having more drugs added to calm the withdrawal effects
  • Seizures and other life threatening physical reactions
  • Violent outbursts or rages
  • REM Sleep Behavior Disorder which has always been known as a drug withdrawal state and is known to include both suicide and homicide – both committed in a sleep state.

Although my book, Prozac: Panacea or Pandora? Our Serotonin Nightmare!, contains massive amounts of information you can find nowhere else on these drugs, it does not have the extensive amount of information contained in the CD focusing mainly on withdrawal issues. The CD contains newer and updated information on safe withdrawal from these drugs. It details over an hour and a half the safest ways found over the past 30 years to withdraw from antidepressants and the drugs so often prescribed with them – the atypical antipsychotics and benzodiazapenes. And it explains why it is safest to withdraw tiny amounts from all of the medications at the same time rather than withdrawing only one at a time.

It also lists many safe alternative treatments that can assist you in getting though the withdrawal and lists other alternatives to avoid which are not safe after using antidepressants. And it contains information on how to rebuild your health after you have had it destroyed by these drugs so that you never end up feeling a need to be on these drugs again.

The CD is very inexpensive and will save you thousands in medical bills which far too many end up spending trying to do it on your own without this information. (One woman who decided she was okay coming down twice as fast as recommended paid a terrible price. After withdrawing she suffered the REM Sleep Disorder early one morning and attacked her husband with a baseball bat (for which she has no memory) and which ended their lifelong courtship and marriage. And cost her $30,000 to be in a psychiatric facility where they put her on five more drugs plus the antidepressant she had just withdrawn from! You can see why many have lamented that they wished they would have had the information on this CD before attempting withdrawal.

To order Ann Blake-Tracy’s book go to: https://store.drugawareness.org/product/prozac-panacea-or-pandora-our-serotonin-nightmare-2014-ebook-download/

To order the CD, “Help! I Can’t Get Off My Antidepressant!” go to: http://store.drugawareness.org/product/help-i-cant-get-off-my-antidepressant-mp3-download/

This is a CD doctors can also benefit from when attempting to withdraw their patients from these drugs which the World Health Organization has now told us are addictive and produce withdrawal. And doctors have begun to recommend the CD to their patients.

The Aftermath of Antidepressants

In 2005 the FDA issued strong warnings about changes in dose for antidepressants. They warned that ANY abrupt change in dose of an antidepressant, whether increasing or decreasing the dose….so that would include switching antidepressants, starting or stopping antidepressants, forgetting to take a pill, skipping doses, taking a pill one day & not the next, etc…. can cause suicide, hostility, and/or psychosis – generally a manic psychosis which is why so many are given a diagnosis for Bipolar Disorder after this withdrawal reaction that can so severely impair sleep leading to a psychotic break.

Clearly coming down too rapidly can be very, very dangerous. We encourage you to arm yourself with knowledge by downloading our CD on safe withdrawal.

http://www.drugawareness.org/wp-content/uploads/wpsc/product_images/thumbnails/helpicant.jpgclick here. order a CD download.

WARNING: In sharing this information about adverse reactions to antidepressants I always recommend that you also give reference to my CD on safe withdrawal, Help! I Can’t Get Off My Antidepressant!, so that we do not have more people dropping off these drugs too quickly – a move which I have warned from the beginning can be even more dangerous than staying on the drugs!

The FDA also now warns that any abrupt change in dose of an antidepressant can produce suicide, hostility or psychosis. And these reactions can either come on very rapidly or even be delayed for months depending upon the adverse effects upon sleep patterns when the withdrawal is rapid! You can find the CD on safe and effective withdrawal helps here: http://store.drugawareness.org/

Ann Blake Tracy, Executive Director,
International Coalition for Drug Awareness
www.drugawareness.org & http://ssristories.drugawareness.org
Author: ”Prozac: Panacea or Pandora? – Our Serotonin Nightmare – The Complete Truth of the Full Impact of Antidepressants Upon Us & Our World” & Withdrawal CD “Help! I Can’t Get Off My Antidepressant!”


23,567 total views, 51 views today

Baum, Hedlund, Aristei, Guilford & Schiavo vs. Glaxo Smithkline Corporation

LA judge denies class action for Glaxo Paxil suit


A U.S. judge in Los Angeles on Monday denied a request to certify as a class action a lawsuit claiming that GlaxoSmithKline Plc’s (GSK) anti-depressant Paxil is habit-forming. U.S. District Judge Mariana Pfaelzer said in her ruling that attorneys for a group of Paxil users failed to present a manageable trial plan.

Baum, Hedlund, Aristei, Guilford & Schiavo vs. Glaxo Smithkline Corporation


LA judge denies class action for Glaxo Paxil suit


To learn more, go to http://www.baumhedlundlaw.com.

A U.S. judge in Los Angeles on Monday denied a request to certify as a class action a lawsuit claiming that GlaxoSmithKline Plc’s (GSK) anti-depressant Paxil is habit-forming.

U.S. District Judge Mariana Pfaelzer said in her ruling that attorneys for a group of Paxil users failed to present a manageable trial plan.

Glaxo, Europe’s biggest drug maker, argued that it would be difficult for the court to determine if each member of a large class experienced the alleged withdrawal symptoms, including nausea and dizziness.

In October, Pfaelzer rejected a request from the same attorneys that advertisements stating that Paxil is “non-habit forming” be permanently barred.

The company was supported in court by the U.S. Food and Drug Administration, which said it had previously reviewed in-depth Paxil’s side effects and concluded that the drug is not habit forming and, as a result, the ads did not mislead.

The Paxil users are suing the British-based drug maker in federal court in Los Angeles, claiming that it deliberately played down the severity of withdrawal symptoms associated with abruptly stopping the drug.

Paxil, Glaxo’s top-selling product, reached sales of $2.7 billion last year.

©2002 Reuters Limited.

1,131 total views, 1 views today

Donald Schell vs. SmithKline Beecham

Donald Schell vs. SmithKline Beecham

Glaxo Raises White Flag, Settles Paxil Trial Appeal, and Pays Up

Rick Giombetti

In a bombshell comparable to the recent belated revelation of the disaster that hormone replacement therapy has been, I have learned that Paxil manufacturer Glaxo-Smith-Kline (GSK) has secretly settled its appeal of the ruling in the Paxil trial last year.
Donald Schell vs. SmithKline Beecham


Glaxo Raises White Flag, Settles Paxil Trial Appeal, and Pays Up


Rick Giombetti

In a bombshell comparable to the recent belated revelation of the disaster that hormone replacement therapy has been, I have learned that Paxil manufacturer Glaxo-Smith-Kline (GSK) has secretly settled its appeal of the ruling in the Paxil trial last year.

GSK was sued in federal district court in Cheyenne by family members of Donald Schell, the Gillette, Wyoming man who killed his wife, daughter, granddaughter and then himself on February 13, 1998 after two days on the pharmaceutical giant’s anti-anxiety/depression drug Paxil. The plaintiff’s position was that Paxil was the primary cause of Donald Schell’s actions in the murder-suicide. The jury agreed and the judge in the trial rejected GSK’s challenge of the validity of the scientific data presented to the jury by the plaintiff’s. As a public service I will be publishing the crucial expert testimony and cross examination of British psychiatrist and psychiatric historian David Healy soon.

GSK appealed the verdict in the case in Denver, but recently gave up, I have been told by Healy. The deal in the appeal settlement GSK made with the plaintiff’s calls for the company getting all of its documents back, and a set of confidentiality statements from the plaintiffs side to not release anymore details of the case not already in the public domain. This is an important development in the history of psychiatric medicine. The jury verdict forced GSK to cave in to the demands of the Medicines Control Agency, the British government agency that regulates prescription drugs, that it place a suicide warning on Paxil. GSK has had to place a suicide warning on Paxil in Britain for about a year now. Now the question remains will this same warning ever make it over to this side of the Atlantic, with as much publicity as the hormone replacement story has gotten? Not likely, I believe, but I hope I am wrong.

Even though there isn’t a widely publicized suicide warning being given for Paxil, or any other drug in its class, known as “Selective Serotonin Reuptake Inhibitors,” or “SSRI’s,” it’s not like there is a complete information black out about these newer generation psychiatric drugs in consumer prescription drug guides.

For example, in the recently published 10th edition of The Pill Book, it warns patients taking SSRI’s (i.e. Celexa, Luvox, Paxil, Prozac and Zoloft) that “The possibility of suicide exists in severely depressed patients and may be present until the condition is significantly improved. Severely depressed people should be allowed to carry only small quantities of SSRI’s to limit the risk of overdose.” The term “overdose” can just as easily be read as “killing themselves.” Also, “As many as 1/3 of people taking an SSRI experience anxiety, sleeplessness and nervousness.” In other words all the symptoms that can push a depressed person over the edge and into a suicide attempt. Finally, the recently published 5th edition of The Physicians’ Desk Reference Pocket Guide to Prescription Drugs warns patients considering taking the SSRI known as Zoloft “May also cause mental or emotional symptoms such as: Abnormal dreams or thoughts, aggressiveness, exaggerated feeling well-being, depersonalization (“unreal” feeling), hallucinations, impaired concentration, memory loss, paranoia, rapid mood shifts, SUICIDAL THOUGHTS, tooth-grinding, WORSENED DEPRESSION (emphasis is the authors).”

Now why on Earth are pharmaceutical companies allowed to get away with marketing these drugs as “anti-depressants,” or “anti-anxiety” agents when they can produce in patients exactly what they are supposed to treat at such high rates? This is the deeper question about the mass marketing of these drugs the mass media is simply avoiding by a combination of cowardice, laziness and just outright ignorance in reporting on these issues.

Rick Giombetti is a freelance writer who. lives in Seattle. Visit his website at: http://rjgiombetti.blogspot.com/. He can be reached at: rickjgio@speakeasy.net

2,179 total views, 1 views today